Distal FA pathway inactivation via mutations in FANCD1 occurs in familial cases of breast (2-25%) [13] and ovarian cancer (2-6%) [14], in familial cases of pancreatic cancer (17%) [15] and in sporadic cancers of various tumor entities [16-18]. This evidence concerns the gene FANCA and familial pancreatic carcinoma.